Xenon Pharmaceuticals Inc. Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. (MRK) (JOBS); Xenon Potentially Eligible for up to $185 Million
6/11/2009 7:38:50 AM
More...
|
Xenon Pharmaceuticals Inc. Announces Appointment of VP, Discovery Research
2/6/2008 7:32:52 AM
More...
|
Fifty-Seven Life Science Companies Selected To Present At Invest Northwest(C) 2007
1/5/2007 2:52:16 PM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Buys Rights To Xenon Pharmaceuticals Inc.'s Pain Drug In Japan; Xenon To Receive Up To $75.5 Million Upfront
10/3/2006 9:27:49 AM
More...
|
Xenon Pharmaceuticals Inc. And Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce Agreement To Develop And Commercialize XEN401 For Pain In Japan And Certain Asian Countries
10/2/2006 12:11:41 PM
More...
|
Xenon Pharmaceuticals Inc. Announces A USD $5M Investment By Takeda Research Investment
9/14/2006 2:29:47 PM
More...
|
Xenon Pharmaceuticals Inc. Raises US$31 Million In Private Financing
4/11/2006 1:48:05 PM
More...
|
Xenon Pharmaceuticals Inc. And Novartis Pharma AG (NVS) Sign Drug Development Deal For Obesity And Metabolic Disorders
10/19/2005 5:11:31 PM
More...
|
Xenon Genetics Discovers A Gene Linked To Peripheral Nerve Degeneration
10/19/2005 5:10:42 PM
More...
|
Xenon Genetics Selects Clinical Candidates For Its Metabolic Syndrome Program
10/19/2005 5:09:40 PM
More...
|
|